secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2024-07-19T23:59:59+00:00
Accession:  0001493152-24-028500
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TenX Keane Acquisition extends business combination deadline to August 18, 2024 via $66,667 note from Citius Pharma
--------------------------------------------------------------------------------

- Citius Pharma deposited $66,667 into trust to extend deadline from July 18 to August 18, 2024; fourth monthly extension.
- Prior extensions occurred on April 26, May 17, and June 17, 2024; Company can extend up to November 18, 2024.
- Promissory note is unsecured, bears no interest, and is repayable only upon closing if trust balance >= $2M.
- Extension funded under Merger Agreement; Note is evidenced by Exhibit 10.4 to this 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224028500/0001493152-24-028500-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224028500/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-028500

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer